Mycobacterium xenopiClinical Relevance and Determinants, the Netherlands
Open Access
- 1 March 2008
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 14 (3), 385-389
- https://doi.org/10.3201/eid1403.061393
Abstract
Clinical isolation of M. xenopi represents true infection in 51% of cases; genotype is a major determinant.Keywords
This publication has 21 references indexed in Scilit:
- Drug Susceptibility Testing of Mycobacterium tuberculosis Complex by Use of a High-Throughput, Reproducible, Absolute Concentration MethodJournal of Clinical Microbiology, 2007
- Spondylitis Due to Mycobacterium xenopi in a Human Immunodeficiency Virus Type 1-Infected Patient: Case Report and Review of the LiteratureJournal of Clinical Microbiology, 2005
- Health Impacts of Environmental MycobacteriaClinical Microbiology Reviews, 2004
- Evaluation of INNO-LiPA MYCOBACTERIA v2: Improved Reverse Hybridization Multiple DNA Probe Assay for Mycobacterial IdentificationJournal of Clinical Microbiology, 2003
- First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutolThorax, 2001
- Evaluation of the bactericidal efficiency of a 2% alkaline glutaraldehyde solution on Mycobacterium xenopiJournal of Hospital Infection, 2000
- Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999Thorax, 2000
- Mycobacterium xenopi and related organisms isolated from stream waters in Finland and description of Mycobacterium botniense sp. nov.International Journal of Systematic and Evolutionary Microbiology, 2000
- Epidemiology of mycobacterial diseasesClinics in Dermatology, 1995
- A strain of mycobacterium isolated from skin lesions of a cold-blooded animal, Xenopus laevis, and its relation to atypical acid-fast bacilli occurring in manEpidemiology and Infection, 1959